GB Meka
Stocks to watch

ATRC

Compare

ATRICURE INC · Healthcare

$56.20
▼ 3.2%Close 2026-09-30

Live intraday price

Compare with our price levels

T266.02
T161.70
E147.83
E343.37
SL41.21

Close 2026-09-30: $56.20 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 14.9% · 1 whale recently bought

1 month
▲ 16.2%
3 months
▲ 89.0%
1 year
▲ 61.2%
Analyst target
$53.33 -5.1%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$47.83 -14.9%
E2$46.61 -17.1%
E3$43.37 -22.8%
Targets
T1$61.70 9.8%
T2$66.02 17.5%
T3$70.34 25.2%
Stop-loss
SL$41.21 -26.7%
Whale cost ~$30.65 -45.5%

Risk : reward 1 : 4.2Moves ~$2.16 a day

⚖️ Positives and risks

✓ Positives (4)
  • ●1 whale bought or added last quarter
  • ●Long-term uptrend (above a rising MA200)
  • ●Beat the market (S&P 500) by +79% over 6 months
  • ●Most analysts rate it Buy
! Risks (3)
  • ●Price is +55% above MA200 — already ran a lot
  • ●Price is already above the average analyst target 53.33 (-5%)
  • ●High forward P/E of 135x (lots of growth already priced in)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Privitera Salvatore · Officer

2026-09-23 · 4,519 shares @ $60.00 · pre-planned sale (10b5-1)

$271,140
Sell

GROVES REGINA E · Director

2026-09-11 · 5,313 shares @ $54.22

$288,071
Sell

Privitera Salvatore · Officer

2026-09-08 · 3,657 shares @ $55.00 · pre-planned sale (10b5-1)

$201,135
Sell

Privitera Salvatore · Officer

2026-09-02 · 7,763 shares @ $52.50 · pre-planned sale (10b5-1)

$407,558
Sell

Dahlquist Karl S. · Officer

2026-08-24 · 9,370 shares @ $48.89

$458,099
Sell

Prange Karen · Director

2026-08-05 · 3,564 shares @ $38.80

$138,283
Sell

Yuen Maggie · Director

2026-08-05 · 3,500 shares @ $38.42

$134,470
Sell

Noznesky Justin J · Officer

2026-07-29 · 6,182 shares @ $38.80

$239,862
Sell

WEHRWEIN SVEN · Director

2026-07-28 · 25,000 shares @ $37.84

$946,000
Sell

Doraiswamy Vinayak · Officer

2026-07-28 · 6,000 shares @ $38.88

$233,280
Sell

Prange Karen · Director

2026-05-20 · 3,000 shares @ $28.65

$85,950
Sell

Doraiswamy Vinayak · Officer

2026-05-15 · 5,000 shares @ $28.13

$140,650
Sell

Doraiswamy Vinayak · Officer

2026-03-12 · 5,000 shares @ $29.83

$149,150
Sell

Noznesky Justin J · Officer

2025-11-26 · 5,166 shares @ $37.29

$192,640
Sell

WEHRWEIN SVEN · Director

2025-11-25 · 4,967 shares @ $38.00

$188,746

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-07-23Beat +650%

Actual EPS $0.18 · est. $0.02 · After close

▲ 6.2%

Day 1

+39.8%

Next 20 days

2026-02-17Beat +250%

Actual EPS $0.06 · est. -$0.04 · After close

▼ 2.2%

Day 1

-10.6%

Next 20 days

2025-10-29Beat +91%

Actual EPS -$0.01 · est. -$0.12 · After close

▼ 3.8%

Day 1

+6.0%

Next 20 days

2025-07-29Beat +88%

Actual EPS -$0.02 · est. -$0.16 · After close

▲ 10.7%

Day 1

+6.2%

Next 20 days

2025-04-29Beat +37%

Actual EPS -$0.14 · est. -$0.22 · After close

▼ 13.7%

Day 1

+13.9%

Next 20 days

2025-02-12Beat +46%

Actual EPS -$0.08 · est. -$0.15 · After close

▼ 6.5%

Day 1

-15.9%

Next 20 days

2024-10-29Beat +13%

Actual EPS -$0.17 · est. -$0.20 · After close

▲ 18.3%

Day 1

+3.8%

Next 20 days

Listen to the earnings call or read the full report on ATRC's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$3.0B
Next earnings2026-10-27
P/E (price to earnings)278.0
Forward P/E (on expected earnings)135.2
Revenue growth (YoY)+12.8%
Earnings growth (YoY)-
Net profit margin+1.9%
ROE+2.2%
Debt to equity (D/E)14%
Dividend yield-
Analyst targets (high / low)$65.00 / $36.00
Number of analysts9
Trend and technical indicators
Trend short / mid / longSideways → · Uptrend ↗ · Uptrend ↗
RSI58
MA50 / MA200$48.27 / $36.21
Distance from MA200+55.2%
MACDNegative
1-year high / low$61.70 / $25.36
vs. S&P 500 (6 months)+79.1%
Volume vs. average0.70×